More on CRVO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.9 Score)

Upcoming Events

- Earnings (8/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CervoMed (NQ:CRVO)
Delayed: 3.08 -0.06 (1.91%)
Prev. Close $3.14  
Open$3.08 
52 Wk High$ 
52 Wk Low$ 
Day High$3.18 
Day Low$3.01 
P/E N/A  
EPS$ 
Volume204,069 

Friends, Peers and Foes (?): SCYX, NTHI, AFDG, ATCH, BSAI (more...)

Jul 15, 2026 07:40 AM H.C. Wainwright Reiterates Buy Rating on CervoMed (CRVO)
Jul 14, 2026 04:21 PM Form 8-K CervoMed Inc. For: Jul 14
Jul 14, 2026 07:32 AM CervoMed presents neflamapimod DLB trial data at AAIC 2026
Jul 14, 2026 07:30 AM CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)
Jul 13, 2026 06:40 AM H.C. Wainwright Reiterates Buy Rating on CervoMed (CRVO)
Jul 13, 2026 06:02 AM Form EFFECT CervoMed Inc.
Jul 10, 2026 05:27 PM Form 424B3 CervoMed Inc.
Jul 9, 2026 04:10 PM Form 8-K CervoMed Inc. For: Jul 09
Jul 9, 2026 07:30 AM CervoMed completes enrollment in Phase 2 nfvPPA dementia trial
Jul 9, 2026 07:30 AM CervoMed Announces Completion of Enrollment in Phase 2 Study of Neflamapimod for Nonfluent Variant Primary Progressive Aphasia, a Type of Frontotemporal Dementia
View All Articles

Entities mentioned with CRVO

View All Entities